These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15165528

  • 1. The treatment of restless legs syndrome with intravenous iron dextran.
    Earley CJ, Heckler D, Allen RP.
    Sleep Med; 2004 May; 5(3):231-5. PubMed ID: 15165528
    [Abstract] [Full Text] [Related]

  • 2. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW, Allen RP, Earley CJ.
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [Abstract] [Full Text] [Related]

  • 3. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG.
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [Abstract] [Full Text] [Related]

  • 4. Iron and the restless legs syndrome.
    Sun ER, Chen CA, Ho G, Earley CJ, Allen RP.
    Sleep; 1998 Jun 15; 21(4):371-7. PubMed ID: 9646381
    [Abstract] [Full Text] [Related]

  • 5. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
    Earley CJ, B Barker P, Horská A, Allen RP.
    Sleep Med; 2006 Aug 15; 7(5):458-61. PubMed ID: 16740411
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP, Adler CH, Du W, Butcher A, Bregman DB, Earley CJ.
    Sleep Med; 2011 Oct 15; 12(9):906-13. PubMed ID: 21978726
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
    Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A.
    Sleep Med; 2009 Oct 15; 10(9):973-5. PubMed ID: 19230757
    [Abstract] [Full Text] [Related]

  • 8. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.
    Sleep Med; 2005 Mar 15; 6(2):141-7. PubMed ID: 15716217
    [Abstract] [Full Text] [Related]

  • 9. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Hornyak M, Scholz H, Kiemen A, Kassubek J.
    Sleep Med; 2012 Jun 15; 13(6):732-5. PubMed ID: 22503006
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
    Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD.
    Am J Kidney Dis; 2004 Apr 15; 43(4):663-70. PubMed ID: 15042543
    [Abstract] [Full Text] [Related]

  • 11. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, Ferini-Strambi L.
    Sleep Med; 2007 Aug 15; 8(5):491-7. PubMed ID: 17512780
    [Abstract] [Full Text] [Related]

  • 12. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
    Cuellar NG, Ratcliffe SJ.
    Altern Ther Health Med; 2009 Aug 15; 15(2):22-8. PubMed ID: 19284179
    [Abstract] [Full Text] [Related]

  • 13. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
    Grim K, Lee B, Sung AY, Kotagal S.
    Sleep Med; 2013 Nov 15; 14(11):1100-4. PubMed ID: 23993871
    [Abstract] [Full Text] [Related]

  • 14. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.
    Earley CJ, Heckler D, Allen RP.
    Sleep Med; 2005 Jul 15; 6(4):301-5. PubMed ID: 15978514
    [Abstract] [Full Text] [Related]

  • 15. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
    Benes H.
    Sleep Med; 2006 Jan 15; 7(1):31-5. PubMed ID: 16194624
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome.
    Grote L, Leissner L, Hedner J, Ulfberg J.
    Mov Disord; 2009 Jul 30; 24(10):1445-52. PubMed ID: 19489063
    [Abstract] [Full Text] [Related]

  • 17. Undiagnosed individuals with first-degree relatives with restless legs syndrome have increased periodic limb movements.
    Birinyi PV, Allen RP, Hening W, Washburn T, Lesage S, Earley CJ.
    Sleep Med; 2006 Sep 30; 7(6):480-5. PubMed ID: 16934525
    [Abstract] [Full Text] [Related]

  • 18. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.
    Sleep Med; 2007 Nov 30; 8(7-8):742-52. PubMed ID: 17512789
    [Abstract] [Full Text] [Related]

  • 19. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children.
    Konofal E, Cortese S, Marchand M, Mouren MC, Arnulf I, Lecendreux M.
    Sleep Med; 2007 Nov 30; 8(7-8):711-5. PubMed ID: 17644481
    [Abstract] [Full Text] [Related]

  • 20. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M, Hundemer HP, Quail D, Riemann D, Voderholzer U, Trenkwalder C.
    Clin Neurophysiol; 2007 Jul 30; 118(7):1532-7. PubMed ID: 17531532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.